1 Min Read
July 6 (Reuters) - Cytori Therapeutics Inc:
* Cytori Therapeutics - receives key cell therapy patent for scleroderma, patent has a term at least through 2034 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.